Course description

The Medical Device Introductory Course

With a growing trend in the crossover between pharmaceutical and medical device regulatory affairs, it is becoming increasingly important for pharmaceutical regulatory professionals to be aware of the issues surrounding medical device regulatory affairs.

Put together by practising medical device regulatory affairs professionals, this newly researched and updated course is demanded by regulatory affairs managers who wish to get their people up to speed on current European medical device regulatory practices.

After three days you will return to your office a more confident and proactive medical device regulatory affairs professional who will be able to determine which directives apply to which products, classify medical devices, assess borderlines issues and establish and maintain an internal audit programme and a supplier audit programme.

The course will also enable you to prepare and manage a third party audit, recognise diverse country requirements, advise on how to conduct a clinical investigation and implement a copy approval process.

Do you work at this organisation and want to update this page?

Is there out-of-date information about your organisation or courses published here? Fill out this form to get in touch with us.

Suitability - Who should attend?

Suitable for

Those with 1-2 years experience in Medical Devices
Those who want a broader understanding of Medical Devices
Anyone who works in other areas of Regulatory Affairs who is looking to move into, has an interest in or would like further understanding of Medical Devices
Anyone in medicines regulation who works with Drug Device Combination Products

Outcome / Qualification etc.

Benefits to participants

participants will learn:

The role of the essential requirements / harmonised standards and how to demonstrate conformity.
The different conformity assessment routes and how to select the most appropriate route for their product
The role of risk management in pre and post market phase and be able to advise on a risk management policy and procedure.
The need for clinical evidence for CE marking
The needs of payers and how to include these as part of the development of the device regulatory package.
The key elements within a PMS system
The criteria for vigilance and the Competent Authority (CA) expectations
The minimum requirements and CA expectations for implementing an FSCA.
The impact of marketing literature on regulatory status
The unique requirements of the IVD Directive